Literature DB >> 16928531

Does the presence of preoperative mild or moderate coronary artery disease affect the outcomes of lung transplantation?

Cliff K Choong1, Bryan F Meyers, Tracey J Guthrie, Elbert P Trulock, G Alexander Patterson, Nader Moazami.   

Abstract

BACKGROUND: Significant coronary artery disease (CAD) is an exclusion criterion for lung transplantation at most centers. However, the impact of preoperative noncritical CAD (single or multivessel mild <30% or moderate 30% to 50% stenosis) on the outcomes of lung transplantation is unknown.
METHODS: A retrospective review of 268 adult patients who underwent lung transplantation between June 1998 and June 2003 at Barnes-Jewish Hospital, a tertiary care center affiliated with Washington University School of Medicine, was performed.
RESULTS: Two hundred ten patients had coronary angiography performed as part of their pretransplantation evaluation. Among these patients, 177 patients had no CAD, and 33 patients (mild, 16; moderate, 17) had noncritical CAD. Patients with noncritical CAD were older (59 versus 55 years, p < 0.001) and had a higher prevalence of diabetes (24% versus 9%, p = 0.014) and systemic hypertension (58% versus 36%, p = 0.004) than patients without CAD. There was no significant difference in the underlying lung disease, other comorbidities, type of lung transplantation performed, early postoperative complications, and hospital or late mortality between recipients with or without CAD. Among the patients with noncritical CAD, there was no hospital mortality and no late cardiac mortality. Three recipients with preoperative moderate CAD developed late ischemic cardiac events, and revascularization was performed in 2 of these recipients. Long-term survival was similar among recipients with or without preoperative CAD.
CONCLUSIONS: Preoperative noncritical (mild or moderate) CAD was not associated with increased perioperative morbidity or mortality, and it did not adversely affect short-term or long-term survival. Late ischemic events developed in 18% of the recipients with moderate CAD disease with no effect on mortality.

Entities:  

Mesh:

Year:  2006        PMID: 16928531     DOI: 10.1016/j.athoracsur.2006.03.039

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Serum Amyloid A in lung transplantation.

Authors:  Lucia Vietri; Elena Bargagli; David Bennett; Antonella Fossi; Paolo Cameli; Laura Bergantini; Miriana d'Alessandro; Piero Paladini; Luca Luzzi; Francesco Gentili; Maria Antonietta Mazzei; Donatella Spina; Piersante Sestini; Paola Rottoli
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-15       Impact factor: 0.670

2.  Coronary revascularization in lung transplant recipients with concomitant coronary artery disease.

Authors:  A W Castleberry; J T Martin; A A Osho; M G Hartwig; Z A Hashmi; G Zanotti; L K Shaw; J B Williams; S S Lin; R D Davis
Journal:  Am J Transplant       Date:  2013-09-18       Impact factor: 8.086

Review 3.  Prevalence of obstructive coronary artery disease in patients undergoing lung transplantation: case series and review of the literature.

Authors:  Robert M Jones; Kyle B Enfield; Borna Mehrad; Ellen C Keeley
Journal:  Catheter Cardiovasc Interv       Date:  2013-11-19       Impact factor: 2.692

4.  Preoperative mild-to-moderate coronary artery disease does not affect long-term outcomes of lung transplantation.

Authors:  Giorgio Zanotti; Matthew G Hartwig; Anthony W Castleberry; Jeremiah T Martin; Linda K Shaw; Judson B Williams; Shu S Lin; Robert D Davis
Journal:  Transplantation       Date:  2014-05-27       Impact factor: 4.939

5.  Preoperative cardiac variables of diastolic dysfunction and clinical outcomes in lung transplant recipients.

Authors:  Ajay Yadlapati; Joseph P Lynch; Rajan Saggar; David Ross; John A Belperio; Stephen Weigt; Abbas Ardehali; Tristan Grogan; Eric H Yang; Jamil Aboulhosn
Journal:  J Transplant       Date:  2013-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.